165 related articles for article (PubMed ID: 36109561)
21. Variations in the mRNA expression of poly(ADP-ribose) polymerases, poly(ADP-ribose) glycohydrolase and ADP-ribosylhydrolase 3 in breast tumors and impact on clinical outcome.
Bieche I; Pennaneach V; Driouch K; Vacher S; Zaremba T; Susini A; Lidereau R; Hall J
Int J Cancer; 2013 Dec; 133(12):2791-800. PubMed ID: 23736962
[TBL] [Abstract][Full Text] [Related]
22. Dna is a New Target of Parp3.
Belousova EA; Ishchenko АA; Lavrik OI
Sci Rep; 2018 Mar; 8(1):4176. PubMed ID: 29520010
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of the H3K9 methyltransferase G9A attenuates oncogenicity and activates the hypoxia signaling pathway.
Ho JC; Abdullah LN; Pang QY; Jha S; Chow EK; Yang H; Kato H; Poellinger L; Ueda J; Lee KL
PLoS One; 2017; 12(11):e0188051. PubMed ID: 29145444
[TBL] [Abstract][Full Text] [Related]
24. Novel Function of Lysine Methyltransferase G9a in the Regulation of Sox2 Protein Stability.
Lee JY; Lee SH; Heo SH; Kim KS; Kim C; Kim DK; Ko JJ; Park KS
PLoS One; 2015; 10(10):e0141118. PubMed ID: 26492085
[TBL] [Abstract][Full Text] [Related]
25. G9a drives hypoxia-mediated gene repression for breast cancer cell survival and tumorigenesis.
Casciello F; Al-Ejeh F; Kelly G; Brennan DJ; Ngiow SF; Young A; Stoll T; Windloch K; Hill MM; Smyth MJ; Gannon F; Lee JS
Proc Natl Acad Sci U S A; 2017 Jul; 114(27):7077-7082. PubMed ID: 28630300
[TBL] [Abstract][Full Text] [Related]
26. TBX2 interacts with heterochromatin protein 1 to recruit a novel repression complex to EGR1-targeted promoters to drive the proliferation of breast cancer cells.
Crawford NT; McIntyre AJ; McCormick A; D'Costa ZC; Buckley NE; Mullan PB
Oncogene; 2019 Aug; 38(31):5971-5986. PubMed ID: 31253870
[TBL] [Abstract][Full Text] [Related]
27. PARP3 affects the relative contribution of homologous recombination and nonhomologous end-joining pathways.
Beck C; Boehler C; Guirouilh Barbat J; Bonnet ME; Illuzzi G; Ronde P; Gauthier LR; Magroun N; Rajendran A; Lopez BS; Scully R; Boussin FD; Schreiber V; Dantzer F
Nucleic Acids Res; 2014 May; 42(9):5616-32. PubMed ID: 24598253
[TBL] [Abstract][Full Text] [Related]
28. Hypoxia-Inducible Lysine Methyltransferases: G9a and GLP Hypoxic Regulation, Non-histone Substrate Modification, and Pathological Relevance.
Chopra A; Cho WC; Willmore WG; Biggar KK
Front Genet; 2020; 11():579636. PubMed ID: 33088284
[TBL] [Abstract][Full Text] [Related]
29. Ethanol induced acetylation of histone at G9a exon1 and G9a-mediated histone H3 dimethylation leads to neurodegeneration in neonatal mice.
Subbanna S; Nagre NN; Shivakumar M; Umapathy NS; Psychoyos D; Basavarajappa BS
Neuroscience; 2014 Jan; 258():422-32. PubMed ID: 24300108
[TBL] [Abstract][Full Text] [Related]
30. Changes in chromatin state reveal ARNT2 at a node of a tumorigenic transcription factor signature driving glioblastoma cell aggressiveness.
Bogeas A; Morvan-Dubois G; El-Habr EA; Lejeune FX; Defrance M; Narayanan A; Kuranda K; Burel-Vandenbos F; Sayd S; Delaunay V; Dubois LG; Parrinello H; Rialle S; Fabrega S; Idbaih A; Haiech J; Bièche I; Virolle T; Goodhardt M; Chneiweiss H; Junier MP
Acta Neuropathol; 2018 Feb; 135(2):267-283. PubMed ID: 29149419
[TBL] [Abstract][Full Text] [Related]
31. PARP-2 regulates cell cycle-related genes through histone deacetylation and methylation independently of poly(ADP-ribosyl)ation.
Liang YC; Hsu CY; Yao YL; Yang WM
Biochem Biophys Res Commun; 2013 Feb; 431(1):58-64. PubMed ID: 23291187
[TBL] [Abstract][Full Text] [Related]
32. Parp3 promotes astrocytic differentiation through a tight regulation of Nox4-induced ROS and mTorc2 activation.
Rodriguez-Vargas JM; Martin-Hernandez K; Wang W; Kunath N; Suganthan R; Amé JC; Oliver FJ; Ye J; Bjørås M; Dantzer F
Cell Death Dis; 2020 Nov; 11(11):954. PubMed ID: 33159039
[TBL] [Abstract][Full Text] [Related]
33. Oxygen-dependent regulation of NDRG1 in human glioblastoma cells in vitro and in vivo.
Said HM; Stein S; Hagemann C; Polat B; Staab A; Anacker J; Schoemig B; Theobald M; Flentje M; Vordermark D
Oncol Rep; 2009 Jan; 21(1):237-46. PubMed ID: 19082468
[TBL] [Abstract][Full Text] [Related]
34. A HIF-independent, CD133-mediated mechanism of cisplatin resistance in glioblastoma cells.
Ahmed EM; Bandopadhyay G; Coyle B; Grabowska A
Cell Oncol (Dordr); 2018 Jun; 41(3):319-328. PubMed ID: 29492900
[TBL] [Abstract][Full Text] [Related]
35. Interaction between PARP-1 and HIF-2α in the hypoxic response.
Gonzalez-Flores A; Aguilar-Quesada R; Siles E; Pozo S; Rodríguez-Lara MI; López-Jiménez L; López-Rodríguez M; Peralta-Leal A; Villar D; Martín-Oliva D; del Peso L; Berra E; Oliver FJ
Oncogene; 2014 Feb; 33(7):891-8. PubMed ID: 23455322
[TBL] [Abstract][Full Text] [Related]
36. PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA.
Day TA; Layer JV; Cleary JP; Guha S; Stevenson KE; Tivey T; Kim S; Schinzel AC; Izzo F; Doench J; Root DE; Hahn WC; Price BD; Weinstock DM
Nat Commun; 2017 Apr; 8():15110. PubMed ID: 28447610
[TBL] [Abstract][Full Text] [Related]
37. NDRG2 and NDRG4 Expression Is Altered in Glioblastoma and Influences Survival in Patients with MGMT-methylated Tumors.
Kolodziej MA; Weischer C; Reinges MH; Uhl E; Weigand MA; Schwarm FP; Schänzer A; Acker T; Quint K; Uhle F; Stein M
Anticancer Res; 2016 Mar; 36(3):887-97. PubMed ID: 26976975
[TBL] [Abstract][Full Text] [Related]
38. G9a-mediated repression of CDH10 in hypoxia enhances breast tumour cell motility and associates with poor survival outcome.
Casciello F; Al-Ejeh F; Miranda M; Kelly G; Baxter E; Windloch K; Gannon F; Lee JS
Theranostics; 2020; 10(10):4515-4529. PubMed ID: 32292512
[No Abstract] [Full Text] [Related]
39. p53 and miR-210 regulated NeuroD2, a neuronal basic helix-loop-helix transcription factor, is downregulated in glioblastoma patients and functions as a tumor suppressor under hypoxic microenvironment.
Agrawal R; Garg A; Benny Malgulwar P; Sharma V; Sarkar C; Kulshreshtha R
Int J Cancer; 2018 May; 142(9):1817-1828. PubMed ID: 29226333
[TBL] [Abstract][Full Text] [Related]
40. Rapid detection of the hypoxia-regulated CA-IX and NDRG1 gene expression in different glioblastoma cells in vitro.
Said HM; Polat B; Staab A; Hagemann C; Stein S; Flentje M; Theobald M; Katzer A; Vordermark D
Oncol Rep; 2008 Aug; 20(2):413-9. PubMed ID: 18636206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
